ResMed (RMD) Tops Q3 EPS by 20c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $224.51 +0.40%
EPS Growth %: +5.5%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +5.5%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $2.13, $0.20 better than the analyst estimate of $1.93. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.17 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- KT&G approves KRW 360 billion share buyback and retirement plan
- FactSet acquires BCC Group to expand real-time market data platform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
